poisar

Stocks · News reference

ClearPoint Neuro Lowers FY2026 Sales Guidance from $52.000M-$56.000M to $48.000M-$52.000M vs $53.133M Est

BenzingaBenzinga Newsdesk

ClearPoint Neuro (NASDAQ:CLPT) lowers FY2026 sales outlook from $52.000 million-$56.000 million to $48.000 million-$52.000 million vs $53.133 million estimate.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaAvi Kapoor

    Crude Oil Down Over 5%; McDonald's Earnings Top Views

    U.S. stocks gain with Nasdaq up more than 2% on Tuesday. Dow up 1.79% to 54,129.35, Nasdaq up 2.22% to 26,490.24, S&P 500 up 1.64% to 7,725.48. Tech shares jump 3.8%, utilities down 0.5%. McDonald's beats earnings estimates. Ibotta, Backblaze, Corvex up, Adapthealth, Better Home & Finance, Clearpoint Neuro down.